Showing results (181-190 of 223) with videos related to
Sort By:
Pageof 23
Biomaterials|March 8, 2013
The use of nanoparticulate delivery systems in metronomic chemotherapyDe-Hong Yu, Fu-Qiang Ban, Mei Zhao, et al.CNS Neuroscience & Therapeutics|November 28, 2013
Meserine, a novel carbamate AChE inhibitor, ameliorates scopolamine-induced dementia and alleviates amyloidogenesis of APP/PS1 transgenic miceBi-Yun Shao, Zheng Xia, Qiong Xie, et al.Bioorganic & Medicinal Chemistry Letters|September 13, 2005
Activity and QSAR study of baogongteng A and its derivatives as muscarinic agonistsYin-Yao Niu, Li-Min Yang, Hui-Zhong Liu, et al.Journal of Nanobiotechnology|January 30, 2022
A nano-innate immune system activator for cancer therapy in a 4T1 tumor-bearing mouse modelXiang-Yu Liu, Mao-Hua Zhu, Xiao-Yu Wang, et al.Stem Cells and Development|June 27, 2013
Non-neuronal release of gamma-aminobutyric Acid by embryonic pluripotent stem cellsLin Teng, Ya-Bin Tang, Fan Sun, et al.Advanced Healthcare Materials|January 30, 2024
Oncolytic Peptide-Nanoplatform Drives Oncoimmune Response and Reverses Adenosine-Induced Immunosuppressive Tumor MicroenvironmentYe Wu, Jia-Yi Lin, Yu-Dong Zhou, et al.Zhonghua Yi Xue Za Zhi|June 28, 2008
[Association of variants in APPL1 gene with body fat and its distribution in Chinese patients with type 2 diabetic mellitus]Qi-Chen Fang, Wei-Ping Jia, Fei Gao, et al.Science Translational Medicine|October 6, 2021
Targeting AKR1B1 inhibits glutathione de novo synthesis to overcome acquired resistance to EGFR-targeted therapy in lung cancerKe-Ren Zhang, Yu-Fei Zhang, Hui-Min Lei, et al.Die Pharmazie|February 15, 2018
High-density lipoprotein-biomimetic nanocarriers for glioblastoma-targeting delivery: the effect of shapeJia-Lin Huang, Gan Jiang, Qing-Xiang Song, et al.Oncogene|July 5, 2024
GSTO1 aggravates EGFR-TKIs resistance and tumor metastasis via deglutathionylation of NPM1 in lung adenocarcinomaNing-Xiang Shen, Ming-Yu Luo, Wei-Ming Gu, et al.Pageof 23